Stay updated on Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Sign up to get notified when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The Study Details page revision tag updates from v3.6.2 to v3.6.3, indicating a small platform update to the page.
    Difference
    0.1%
    Check dated 2026-07-03T21:59:32.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page footer's revision tag was updated from v3.6.0 to v3.6.2, indicating a backend or template update; the visible study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-06-26T23:56:12.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    New metadata and navigation elements were added: Weijia Fang, MD appears as the contact line, verification-related labels were introduced, and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. Formatting was standardized from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag was updated to v3.6.0.
    Difference
    2%
    Check dated 2026-06-12T16:31:41.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.4 to v3.5.5, indicating a new version of the page has been published. This revision update is a backend/version control detail rather than a substantive content change.
    Difference
    0.1%
    Check dated 2026-06-05T13:23:38.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page now shows a new revision label Revision: v3.5.4, replacing the prior Revision: v3.5.3. This indicates a minor update to the page's metadata or presentation.
    Difference
    0.1%
    Check dated 2026-05-15T05:50:14.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page’s revision/version footer was updated from **v3.5.2** to **v3.5.3**, reflecting a site build or documentation update rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:56.000Z thumbnail image

Stay in the know with updates to Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.